Charles River Laboratories International (CRL) Payables (2009 - 2025)

Charles River Laboratories International (CRL) has reported Payables for 17 consecutive years, with $148.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Payables rose 6.03% year-over-year to $148.8 million; the TTM figure through Dec 2025 stood at $148.8 million (up 6.03% YoY), while the FY2025 annual figure was $148.8 million, up 6.03% from the prior year.
• Payables came in at $148.8 million for Q4 2025 at Charles River Laboratories International, down from $169.6 million in the prior quarter.
• The five-year high for Payables was $226.0 million in Q1 2022, with the low at $110.9 million in Q2 2021.
• Average Payables over 5 years is $155.4 million, with a median of $143.1 million recorded in 2024.
• Across the five-year window, Payables jumped 90.56% in 2022 and plunged 46.9% in 2023, its largest moves.
• Year by year, Payables stood at $198.1 million in 2021, then gained by 3.93% to $205.9 million in 2022, then retreated by 17.96% to $168.9 million in 2023, then retreated by 16.93% to $140.3 million in 2024, then rose by 6.03% to $148.8 million in 2025.
• According to Business Quant data, Payables over the past three periods registered $148.8 million, $169.6 million, and $145.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.